A01K 2207/25
Animals on a special diet
A01K2207/25 (Animals on a special diet) appears on 36 US grants and 104 published applications in this corpus.
Search patents in A01K- Granted patents
- 36
- Published applications
- 104
- Assignees
- 80
- Inventors
- 214
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 2 |
| 2012 | 0 | 2 |
| 2013 | 1 | 2 |
| 2014 | 0 | 3 |
| 2015 | 1 | 10 |
| 2016 | 1 | 3 |
| 2017 | 3 | 2 |
| 2018 | 4 | 7 |
| 2019 | 2 | 7 |
| 2020 | 0 | 11 |
| 2021 | 2 | 13 |
| 2022 | 3 | 12 |
| 2023 | 3 | 9 |
| 2024 | 2 | 9 |
| 2025 | 7 | 5 |
| 2026 | 7 | 7 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Fullerenes to treat diseases and conditions25 Aug 2026US 12,714,679 B2The Cleveland Clinic Foundation
- Compositions comprising miR-690 and methods therefor16 Jun 2026US 12,653,783 B2The Regents of the University of California
- Aquacultured crustacean and method of producing same2 Jun 2026US 12,642,287 B2Nippon Suisan Kaisha, Ltd.
- Compositions and methods for regulating fatty acids26 May 2026US 12,637,695 B2Shriners Hospitals for Children
- Application of TPK as a target in Alzheimer's disease17 Mar 2026US 12,575,549 B2Shanghai Raising Pharmaceutical Co., Ltd.
- Verification of methane abatement in animals1 Oct 2026US 2026/0293863 A1Commonwealth Scientific and Industrial Research Organisation
- Aquacultured crustacean and method of producing same17 Sep 2026US 2026/0271976 A1Nippon Suisan Kaisha, Ltd.
- Prevention or treatment of fibrotic disease18 Jun 2026US 2026/0167973 A1Kyushu University, National University Corporation
- Viral expression construct comprising a fibroblast growth factor (fgf21) coding sequence21 May 2026US 2026/0139021 A1Universitat Autonoma De Barcelona
- Methods for treating and preventing diseases2 Apr 2026US 2026/0091068 A1
Most cited
By later US patents
- Sulfated oxysterol and oxysterol sulfation by hydroxysterol sulfotransferase promote lipid homeostasis and liver proliferation8US 9,034,859 B2Virginia Commonwealth University · 2015
- Sulfated-oxysterol and oxysterol sulfation by hydroxysterol sulfotransferase promote lipid homeostasis and liver proliferation7US 9,480,692 B2Virginia Commonwealth University · 2016
- Method of treating a metabolic disorder induced by obesity in a subject in need thereof by administering MK2/3 inhibitors4US 9,771,430 B2The Trustees of Columbia University in the City of New York · 2017
- Modulation of SMRT expression2US 8,541,387 B2Isis Pharmaceuticals, Inc. · 2013
- Steatohepatitis-liver cancer model animal1US 9,596,834 B2Stelic Institute of Regenerative Medicine, Stelic Institute & Co. · 2017